The newly acquired ELITech Molecular Diagnostics business also contributed, positioning Bruker as an emerging infectious disease specialist in the in-vitro diagnostics (IVD) market. Within Bruker’s ...
Q4 2024 Earnings Conference Call March 11, 2025 10:00 AM ETCompany ParticipantsMike Critelli - Director, Finance ...
As it happens, Bruker issued 9.5% more new shares over the last year. That means its earnings are split among a greater number of shares. Per share metrics like EPS help us understand how much ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback